Class information for:
Level 1: RESIDUAL THROMBOSIS//RECURRENT VENOUS THROMBOEMBOLISM//ANTICOAGULANT RELATED BLEEDING

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
12569 834 34.6 87%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
200 20446 PULMONARY EMBOLISM//VENOUS THROMBOEMBOLISM//DEEP VEIN THROMBOSIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RESIDUAL THROMBOSIS Author keyword 9 83% 1% 5
2 RECURRENT VENOUS THROMBOEMBOLISM Author keyword 7 43% 1% 12
3 ANTICOAGULANT RELATED BLEEDING Author keyword 6 80% 0% 4
4 THROMBOEMBOLISM UNIT Address 6 33% 2% 16
5 RESIDUAL VEIN OBSTRUCTION Author keyword 6 100% 0% 4
6 ANGIOL BLOOD COAGULAT MARINO GOLINELLI Address 5 29% 2% 15
7 EA 3878 Address 4 30% 1% 11
8 RESIDUAL VEIN THROMBOSIS Author keyword 3 100% 0% 3
9 HEMATOL GRP HERG Address 3 37% 1% 7
10 HEMATOL GRP Address 3 27% 1% 9

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 RESIDUAL THROMBOSIS 9 83% 1% 5 Search RESIDUAL+THROMBOSIS Search RESIDUAL+THROMBOSIS
2 RECURRENT VENOUS THROMBOEMBOLISM 7 43% 1% 12 Search RECURRENT+VENOUS+THROMBOEMBOLISM Search RECURRENT+VENOUS+THROMBOEMBOLISM
3 ANTICOAGULANT RELATED BLEEDING 6 80% 0% 4 Search ANTICOAGULANT+RELATED+BLEEDING Search ANTICOAGULANT+RELATED+BLEEDING
4 RESIDUAL VEIN OBSTRUCTION 6 100% 0% 4 Search RESIDUAL+VEIN+OBSTRUCTION Search RESIDUAL+VEIN+OBSTRUCTION
5 RESIDUAL VEIN THROMBOSIS 3 100% 0% 3 Search RESIDUAL+VEIN+THROMBOSIS Search RESIDUAL+VEIN+THROMBOSIS
6 ANTICOAGULATION DURATION 2 67% 0% 2 Search ANTICOAGULATION+DURATION Search ANTICOAGULATION+DURATION
7 DURATION OF ANTICOAGULATION 2 67% 0% 2 Search DURATION+OF+ANTICOAGULATION Search DURATION+OF+ANTICOAGULATION
8 UNPROVOKED 2 40% 0% 4 Search UNPROVOKED Search UNPROVOKED
9 RECURRENT VENOUS THROMBOSIS 2 36% 0% 4 Search RECURRENT+VENOUS+THROMBOSIS Search RECURRENT+VENOUS+THROMBOSIS
10 DURATION OF ANTICOAGULANTS 1 100% 0% 2 Search DURATION+OF+ANTICOAGULANTS Search DURATION+OF+ANTICOAGULANTS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTENSITY WARFARIN THERAPY 44 42% 10% 82
2 ARTERIAL CARDIOVASCULAR EVENTS 38 78% 3% 25
3 ORAL ANTICOAGULANT THERAPY 13 11% 14% 117
4 ANTICOAGULATION WITHDRAWAL 13 61% 2% 14
5 LOW INTENSITY WARFARIN 9 64% 1% 9
6 RECURRENT VENOUS THROMBOEMBOLISM 9 12% 9% 73
7 THROMBOEMBOLISM ETIOLOGY 9 55% 1% 11
8 FIRST EPISODE 9 16% 6% 51
9 PATIENT LEVEL METAANALYSIS 8 43% 2% 15
10 STOPPING TREATMENT 8 75% 1% 6

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor A Systematic Review 2010 57 19 89%
Treatment of Venous Thromboembolism 2014 23 74 26%
Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review 2011 23 18 67%
Risk assessment for recurrent venous thrombosis 2010 64 95 46%
Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review 2013 18 22 32%
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of D-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism 2010 45 39 51%
Obesity and Venous Thrombosis: A Review 2011 38 36 33%
Association between venous and arterial thrombosis: Clinical implications 2012 14 52 73%
Optimal treatment duration of venous thrombosis 2013 6 46 61%
Venous Thromboembolism Risk Factors for Recurrence 2009 76 107 42%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 THROMBOEMBOLISM UNIT 6 33% 1.9% 16
2 ANGIOL BLOOD COAGULAT MARINO GOLINELLI 5 29% 1.8% 15
3 EA 3878 4 30% 1.3% 11
4 HEMATOL GRP HERG 3 37% 0.8% 7
5 HEMATOL GRP 3 27% 1.1% 9
6 THROMBOSIS PROGRAM 3 19% 1.6% 13
7 CARDIOTHORAC VASC SCI 2 14% 1.8% 15
8 CATTEDRA UNITA EMATOL CON TR IANTO 2 67% 0.2% 2
9 TROMBOSI 2 19% 1.0% 8
10 INTERNAL MED CHEST DIS 2 13% 1.4% 12

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000203593 FACTOR V LEIDEN//APC RESISTANCE//ACTIVATED PROTEIN C RESISTANCE
2 0.0000189692 POST THROMBOTIC SYNDROME//MAY THURNER SYNDROME//POSTTHROMBOTIC SYNDROME
3 0.0000143792 THROMBOPROPHYLAXIS//VENOUS THROMBOEMBOLISM//DEEP VEIN THROMBOSIS
4 0.0000117687 JOBST VASC SURG//CONRAD JOBST VASC S//SOLUBLE P SELECTIN
5 0.0000115116 RIVAROXABAN//DABIGATRAN//APIXABAN
6 0.0000112647 D DIMER//DISTAL DEEP VEIN THROMBOSIS//CALF VEIN THROMBOSIS
7 0.0000097631 PULMONARY EMBOLISM//MASSIVE PULMONARY EMBOLISM//ACUTE PULMONARY EMBOLISM
8 0.0000097457 LOW MOLECULAR WEIGHT HEPARIN//UNFRACTIONATED HEPARIN//ANTI XA ACTIVITY
9 0.0000097207 CANCER PROCOAGULANT//TISSUE FACTOR//CANCER ASSOCIATED THROMBOSIS
10 0.0000084158 PULMONARY EMBOLISM//EMBOLISM PULMONARY//PULMONARY ANGIOGRAPHY